Inhibition of cytochrome P450 epoxygenase promotes endothelium-to-mesenchymal transition and exacerbates doxorubicin-induced cardiovascular toxicity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Inhibition of cytochrome P450 epoxygenase promotes endothelium-to-mesenchymal transition and exacerbates doxorubicin-induced cardiovascular toxicity ; volume:51 ; number:1 ; day:27 ; month:7 ; year:2024 ; pages:1-19 ; date:12.2024
Molecular biology reports ; 51, Heft 1 (27.7.2024), 1-19, 12.2024
- Urheber
-
Dhulkifle, Hevna
Therachiyil, Lubna
Hasan, Maram H.
Sayed, Tahseen S.
Younis, Shahd M.
Korashy, Hesham M.
Yalcin, Huseyin C.
Maayah, Zaid H.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11033-024-09803-z
- URN
-
urn:nbn:de:101:1-2410122129594.890097585696
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dhulkifle, Hevna
- Therachiyil, Lubna
- Hasan, Maram H.
- Sayed, Tahseen S.
- Younis, Shahd M.
- Korashy, Hesham M.
- Yalcin, Huseyin C.
- Maayah, Zaid H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Doxorubicin-induced ovarian toxicity
Inhibition of chymotryptic-like standard proteasome activity exacerbates doxorubicin-induced cytotoxicity in primary cardiomyocytes
Empagliflozin prevents doxorubicin-induced myocardial dysfunction
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation
A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells
PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Glycine protects against doxorubicin-induced heart toxicity in mice
The progression of doxorubicin-induced intestinal mucositis in rats
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Doxorubicin-induced ovarian toxicity
Inhibition of chymotryptic-like standard proteasome activity exacerbates doxorubicin-induced cytotoxicity in primary cardiomyocytes
Empagliflozin prevents doxorubicin-induced myocardial dysfunction
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation
A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells
PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Glycine protects against doxorubicin-induced heart toxicity in mice
The progression of doxorubicin-induced intestinal mucositis in rats
Doxorubicin-induced cardiotoxicity in adult Indian patients on chemotherapy
Doxorubicin-induced ovarian toxicity
Inhibition of chymotryptic-like standard proteasome activity exacerbates doxorubicin-induced cytotoxicity in primary cardiomyocytes
Empagliflozin prevents doxorubicin-induced myocardial dysfunction
Rifampicin efficacy against doxorubicin-induced cardiotoxicity in mice
MST1 mediates doxorubicin-induced cardiomyopathy by SIRT3 downregulation
A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells
PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells
Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat
Glycine protects against doxorubicin-induced heart toxicity in mice
The progression of doxorubicin-induced intestinal mucositis in rats